Abstract. Ninety-five inpatients completed a dexamethasone suppression test (DST) within 72 hours after admission and again after at least I week of medication-free hospital care. The frequency of cortisol nonsuppression in patients with endogenous depression (ED) was high and not significantly different at both tests. In patients with diagnoses other than ED, the higher rate of cortisol nonsuppression at the first DST was associated with a significant decrease in test specificity. Change in postdexamethasone cortisol levels at repeat testing was associated with a decrease in depressive symptomatology, but was not related to weight change during hospitalization.
Several reviews of the literature have concluded that, in certain specific situations, the dexamethasone suppression test (DST) can contribute to the diagnostic evaluation of depression ; APA Task Force on Laboratory Tests in Psychiatry, 1987) . Although the controversy associated with this topic has many sources (Carroll, 1985) some of the discrepancies in reported findings have been associated with the spread of DST studies into general clinical settings. Most early studies examined the performance of the DST in patients on research units; the patients usually were drug free and had been hospitalized for l-2 weeks before the test was performed.
These restrictions tend to emphasize the specific effects of depressive illness on the hypothalamic-pituitary-adrenal (HPA) axis and to diminish the nonspecific effects of other factors that activate this endocrine system. These factors include "psychological stress" (Mason, 1968; Blumenfield et al., 1970) admission to the hospital (Mason et al., 1965; Sachar, 1967; Swigar et al., 1979) and withdrawal from medications (Devanand et al., 1984; Dilsaver and Greden, 1985) or acute alcohol withdrawal (Swartz and Dunner, 1982; Newsom and Murray, 1983; Ravi et al., 1984; DelPorto et al., 1985) .
Although many psychiatrists in clinical practice have ordered the DST promptly after the patient's hospital admission, we cannot assume that the DST will provide optimal diagnostic information when used in this way. In an earlier study , we reported no significant drop in sensitivity of the DST for melancholic inpatients as the drug-free period of observation was extended from l-3 days to at least 10 days. No comparable data on nonmelancholic patients were discussed. Thus, although the sensitivity of the DST was unrelated to the length of time in the hospital, it does not necessarily follow that the same is true for the specificity of the test. A retrospective examination of case records (Coccaro et al., 1984) revealed that depressed patients who completed a DST on day 2 of hospitalization had a higher frequency of cortisol nonsuppression (71%) than depressed patients who were tested on days 3-6 (33%). This difference did not appear to result from an association between the severity of depression and the day of DST completion.
A similar review of 42 depressed patients (Roy-Byrne et al., 1984) found a nonsignificant trend toward more frequent cortisol nonsuppression when patients were tested on days I or 2 of hospitalization compared with days 4, 5, or 6. By contrast, the results obtained in depressed patients were highly replicable in another study when the DST was completed on days 8 and 15 of hospitalization (Charles et al., 1982) . In this study, we completed a DST first within 72 hours of hospitalization and again in the same patients after a medication-free evaluation period. This design permitted the assessment of any "admission effect" on the sensitivity, specificity, and predictive validity of the DST, as well as the test-retest reliability during the first 3 weeks of inpatient care.
Methods
Patients. This study was conducted on a 22-bed general psychiatric unit and included 95 consecutively admitted patients with the prominent symptom of depressed mood. On this unit, it was standard practice to discontinue all psychotropic medications gradually during the first week of hospitalization and complete a drug-free diagnostic evaluation during the subsequent week. Patients were excluded from the study if they were less than 80% of ideal body weight, suffered from physical illness, were taking medications known to affect the DST or were unable to complete the drug-free evaluation. Diagnostic evaluation included a structured interview using the Schedule for Affective Disorders and Schizophrenia (SADS) (Endicott and Spitzer, 1978) and used all available history and clinical observations. The diagnosis, according to Research Diagnostic Criteria (RDC) (Spitzer et al., 1978) , was determined at the completion of the evaluation period by a consensus of the treating psychiatrist and the SADS interviewer.
We studied 58 women and 37 men whose ages were 40.6 + 15.3 years and 30.0 + 10.0 years, respectively (mean + SD). Sixty-two patients were diagnosed as suffering from a depressive disorder by RDC. Thirty-seven of these met criteria for major depressive disorder (MDD), definite endogenous subtype (ED). The remaining 25 met criteria for MDD, not or only probable endogenous subtype; episodic minor depressive disorder; or chronic and intermittent depressive disorder (NED). The ratio of females to males was 2:1 in both ED and NED groups, and the mean ages were 43.6 years (range 2 l-73) and 32.7 years ( 19-60) respectively. The remaining patients received diagnoses of manic disorder (MAN) (n = I I); schizoaffective disorder, depressed type (SA-D) ( n = IO); schizoaffective disorder, manic type (SA-M) (n = 7); or schizophrenia (SCH) (n = 5).
Procedure. All patients completed a DST on two occasions before beginning treatment. Patients received dexamethasone at I I:30 p.m. on day I or 2 of inpatient care (DST-I), and plasma cortisol was measured at 4 p.m. and I I p.m. on the following day. The test was repeated after 7-21 days of hospitalization (DST-II). DST-I could therefore have occurred in the absence of recent medication ingestion, during the discontinuation of known medications, or following the abrupt discontinuation of alcohol, marijuana, or undisclosed medications. DST-II always occurred at least 7 days after cessation of medication and after at least I week in the hospital. The DST followed the procedure described by Carroll et al. (198 I) , using I mg of dexamethasone, and the result was considered nonsuppressive/abnormal if either the 4 p.m. or I I p.m. postdexamethasone plasma cortisol value exceeded 5 pg/dl. Plasma cortisol was determined using a competitive protein-binding method (Wilens et al., 1984) . In our laboratory, the typical coefficients of variation are 12.5% (interassay) and 6.5% (intra-assay) with low cortisol samples (mean cortisol concentration, 2.5 pg/dl), and 9.0% (interassay) and 5.5% (intra-assay) with high cortisol samples (mean cortisol concentration, lO.O~g/dl). Clinical ratings of severity were obtained at the time of each DST using the Hamilton Rating Scale for Depression (HRSD) (Hamilton, 1960) . The results of the DST were not released to the investigators until the diagnostic evaluation was complete.
Data Analysis. Two sets of analyses were performed on the dependent measures derived from the DST results. First, we calculated the frequency of "DST nonsuppression"
in each diagnostic group and examined changes in test performance between DST-I and DST-II. The significance of a change in frequency between DST-I and DST-II was assessed using the McNemar x2 test for dependent samples (McNemar, 1947) . The 95% confidence limits (CL-95) for estimates of conditional probabilities (sensitivity, specificity, and predictive validity) were determined as described previously (Kalter et al., 1983) . A Kappa statistic was calculated for each patient group as a measure of agreement in test result between DST-I and DST-II (Cohen, 1960) .
In a separate analysis, we examined the actual change in maximum postdexamethasone cortisol levels at DST-I and DST-II. The cortisol values were log-transformed to improve the normality of distribution before the use of parametric statistical tests (skewness at DST-I and DST-II, respectively, was 0.97 and 1.32 for raw cortisol values and -0.73 and 0.24 after log transformation).
To explore the relationship between diagnosis and change in postdexamethasone cortisol values, age, weight, and HRSD score, we used a two-way analysis of variance (ANOVA) with diagnosis as a grouping factor and time as the repeated measures dimension or a one-way ANOVA as appropriate.
The associations between change in postdexamethasone cortisol values and patient's age, weight, and HRSD score were studied by analyses of covariance (ANCOVAs). Table 1 shows that the frequency of abnormal DST results in all studied patients significantly decreased from 55% at DST-I to 36% at DST-II @ < 0.01). Although the sensitivity (i.e., frequency of an abnormal DST in patients with ED) also appeared to decrease from 70% at DST-I to 59% at DST-II, the presence of a clear overlap in the CL-95 for each estimate (55%-85% and 43%-75%, respectively) indicates that this change is inconclusive.
Results
By comparison, the overall specificity (i.e., frequency of a normal DST in patients with diagnoses other than ED) increased from 55% at DST-I to 79% at DST-II, and there was no overlap in the CL-95 for each estimate (45%-65% and 7 I %-87%, respectively).
The agreement in test results between DST-1 and DST-II also tended to be higher in patients with ED than in other patients. The value of Kappa for the ED patients was 0.53, and in the remaining patients it was 0.19. The CL-95 for the difference 
in these Kappa values is 0.34 +_ 0.38, which just overlaps zero. A one-sided t test gives a p value of 0.04. Further examination of ED patients who also met psychotic subtype revealed that 92% of DST results were unchanged (12/ 13) and 77% (IO/ 13) were abnormal at both times. Eight patients also met criteria for alcoholism during the index episode, and three had an abnormal result at DST-I (their concurrent diagnoses were ED, SA-D, and SCH). None developed a clinically evident withdrawal syndrome, and all suppressed cortisol normally at DST-II. Table 2 summarizes the mean postdexamethasone cortisol levels for each diagnostic group. Similar to the frequency of nonsuppression, the actual cortisol levels decreased in all diagnostic groups between DST-I and DST-II. In the ED patients, however, the mean cortisol level at DST-II remained higher than the criterion for nonsuppression, while the comparable value in patients with NED, MAN, or SCH fell below the criterion. Because of small numbers of patients in many There was a trend for the HRSD score to contribute to the between group differences in cortisol level (ED:OTHER, p = 0.09; ED:OTHDEPR, p = 0.07). After the HRSD effect was controlled for, however, the main effect for diagnosis continued to have a significant effect on the variance in cortisol level (ED:OTHER, p = 0.006; ED:OTHDEPR, p = 0.002).
When all patients in the study were considered, the HRSD score was a significant covariate on the differences in cortisol level between tests (ED:OTHER, p = 0.03) and after the HRSD score was controlled for, the main effect for time was no longer significant (ED:OTHER, p = 0.09). If only the patients with a depressive syndrome were considered, the HRSD score did not significantly contribute to the withinsubject variation in cortisol level between the two tests (ED:OTHDEPR, p = 0.03).
These results suggest that patients with ED had significantly more severe depressive symptomatology and that, although there was a significant decrease in severity between tests, the magnitude of the decrease was not significantly different between the ED patients and either comparison group. Although the HRSD score may contribute to the cortisol level differences between diagnostic groups, other factors are clearly important.
The effect of the decrease in HRSD score between tests on the cortisol levels appears to be significant when all patients are considered in contrast to the nonsignificant effect when only patients with depressive syndromes are examined.
A similar analysis of patient weights revealed no significant main effects for group (ED:OTHER,p = 0.07 and ED:OTHDEPR,p=OJ) or time (ED:OTHER,p = 0.4 and ED:OTHDEPR, On the basis of the medication history obtained at the time of admission, patients were categorized as medication free or withdrawn from one of the common classes of psychotropic medications, ethanol, or cannabis (Table 4 ). Many patients were withdrawn from multiple medications, and therefore the sum of the percentages is > 100%. When patients with ED were compared to all other patients (OTHER), it was apparent that the more frequent change from nonsuppression to suppression in the OTHER group could not be clearly related to withdrawal from any specific group of medications. 
p = 0. I). (See
Note. S = dexamethasone suppression test (DST) suppression. NS = DST nonsuppression. ED = endogenous depression. OTHER = all other patients. NED = nonendogenous depression. SA-D = schrzoaffectrve disorder, depressed. SA-M = schizoaffective disorder, manic. SCH = schizophrenra.
Discussion
Our principal finding was that completion of the DST within 72 hours of admission produced a higher frequency of cortisol nonsuppression than occurred when the DST was delayed until week 2 of hospitalization after the patients had been medication free for 1 week. Although the frequency of abnormal results at DST-I was increased in most diagnoses, the difference between DST-I and DST-11 was inconclusive in the 37 patients with ED. This is in agreement with our previous report (Carroll et al., 198 I) of no significant change in DST sensitivity for ED after hospitalization and withdrawal from medication. In patients with diagnoses other than ED, however, the increase in frequency of abnormal results of DST-I was associated with a significant decrease in test specificity.
The change in frequency of cortisol nonsuppression between DST-I and DST-II also altered the predictive value of an abnormal DST for ED (PV+) (percentage of patients with an abnormal DST result having a diagnosis of ED). Administration of the DST to all newly admitted patients resulted in a PVS of 50% (CL-95 = 40% 60%). When the test was administered to the same patients after at least I week free of medication and after at least I week in the hospital, the PV+ increased to 65% (CL-95 = 55%75%). Since PV+ is also dependent upon the prevalence of ED in the tested group (Vecchio, 1966; further improvement can be achieved by increasing the expected prevalence of ED in the sample. If the second test had been administered to only those patients with depressive syndromes (ED, NED, and SA-D), the PV+ would have been 76% (CL-95 = 66%-86%); after 1 week in hospital and medication free, nearly 8 out of every 10 depressed patients with an abnormal result at DST-II met diagnostic criteria for ED.
The results also reinforce the earlier warning about interpretation of DST results in newly admitted psychotic patients (Carroll et al., 1976) . This caution is supported by the report of Herz et al. (1985) , who found cortisol nonsuppression in 73% of patients with schizophrenia or schizoaffective disorder when the DST was completed on days I and 2 of hospitalization.
In most of their patients, the DST result normalized after 1 week's treatment with neuroleptic medication.
Our own results suggest that normalization of the DST in psychotic but nondepressed patients (SA-M and SCH) will frequently occur after 1 week of inpatient care without definitive drug treatment.
This contrasts with the results from psychotic patients who also manifested a depressed syndrome (SA-D, ED-psychotic subtype); these patients had a similar frequency of cortisol nonsuppression at both times of testing. In this sample, patients with MAN had a low frequency of cortisol nonsuppression, which was much lower than the frequency in patients meeting criteria for SA-M. Although other reports have noted a high frequency of cortisol nonsuppression in mania (Graham et al., 1982; data from studies that have used alternative diagnostic criteria (such as DSM-III or ICD-9) to categorize affective syndromes cannot be compared directly to studies that used the RDC (Davidson et al., 1984) . Despite having the same "diagnoses," groups of manic patients diagnosed at different centers by varying diagnostic criteria will not be strictly comparable.
The factors responsible for the frequent change from cortisol nonsuppression at DST-I to suppression at DST-II cannot be comprehensively addressed in this study. Although physiological factors, such as inadequate hydration, poor food intake with associated ketosis, and disrupted circadian rest-activity cycles, may be suspected Table 2 indicates that an equivalent decrease in absolute postdexamethasone cortisol levels in the ED group did not have the same impact on the frequency on nonsuppression because, in these patients, most values still remained above the 5 pg/dl criterion.
Several studies have found a positive correlation between age and postdexamethasone cortisol levels in depressed patients (Asnis et al., 1981; Lewis et al., 1984; Stokes et al., 1984) . Although our patients with ED were significantly older than the patients with other diagnoses, ANCOVA revealed that the betweendiagnosis difference in the postdexamethasone cortisol levels remained significant after controlling for the age difference. Similarly, there have been reports indicating that severity of depressive symptomatology is positively associated with cortisol nonsuppression (Miller and Nelson, 1987; Meador-Woodruff et al., 1988) . In this study, it was expected that more severe depressive features would be present in patients with ED, but even after the difference in severity of depression was controlled for, postdexamethasone cortisol levels in ED patients remained significantly higher than the levels in patients with other diagnoses. Our results also documented a modest but generalized decrease in symptomatology during the medication-free evaluation.
The beneficial effect of the inpatient milieu, although sometimes not sustained, has been commonly observed in patients with a wide range of presentations.
Once this decrease in HRSD score was controlled for, the fall in postdexamethasone cortisol levels between DST-1 and DST-II was no longer significant, suggesting that the improvement in symptomatology and the decrease in cortisol levels were closely associated. Contrary to earlier suggestions that weight loss might be responsible for abnormal DST results (Berger et al., 1983; Edelstein et al., 1983) we found no significant relationship between change in weight and change in postdexamethasone cortisol level in the hospital.
In conclusion, our results indicate that abnormal DST results are common but transient among nondepressed psychotic patients during the first 3 days after hospital admission.
Nonsuppression rates are also elevated soon after admission in patients with mania and NED, though to a lesser extent than in psychotic patients. In patients with ED, a high rate of nonsuppression persisted well beyond the first days of hospitalization.
The practical lesson from these results is that the diagnostic performance of the DST will be reduced if it is performed during the first few days after patients enter the hospital.
